14 (9), e29696
Brands must now move beyond short-term fixes and prepare for behavior-driven health expectations
Neuropathic pain affects 7% to 10% of people in the general population, but it is much higher in people with diabetes between 20% and 30% (Baskozos et al., 2023)
The product was removed from refrigerated storage for an extended period of time.Recall Initiation Date: April 9, 2025Link: FDA Enforcement Report Facility Inspections FDA Warning Letters ProRx, LLC Type: Compounding pharmacy and FDA-registered outsourcing facilityFDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Warning Letter Date: January 15, 2025Facility Location: Exton, PennsylvaniaInspection Dates: July 15, 2024, to August 2, 2024
Biochim Biophys Acta 1830:41174129
In some cases, doctors may still prescribe them off-label (for other uses that are not FDA-approved), depending on individual needs and their own medical judgement